Mkts

InMed Pharmaceuticals Inc.

NASDAQ: INM
$14.70-0.54 (-3.54%)
As of Nov 19, 7:00 PM ET

Key statistics

Day range
13.0114.78
52-week range
5.7523.30
Today
Open14.72
Previous close14.70
Volume125.9K
Valuation
Market cap9.61M
P/E ratio—
EPS (TTM)-2.88
Income & risk
Dividend / yield—
Beta1.05
Avg volume75.2K
Discussion

INM News

Stories mentioning INM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue820.001,1201,3041,2621,1121,2651,283
Cost of Goods Sold636.00717.00728.001,086651.00771.00817.00
Gross Profit0.00184.00403.00577.00176.00461.00493.00467.00
Operating Expenses
Research & Development1,023631.00582.00834.00425.00895.00700.00659.00
Sales General & Admin
Total Operating Expenses2,8402,2872,2242,6262,0842,7152,2282,500
Operating Income (Loss)
Interest Income48.0074.0094.0051.0017.0031.0057.00104.00
Interest Expense
Other Expense
Pretax Income(2,792)(2,028)(1,727)(1,842)(2,067)(2,575)(1,678)(1,930)
Tax Provision
Net Income (Loss)(2,966)(2,028)(1,727)(1,788)(2,121)(2,575)(1,678)(1,938)
Earnings Per Share (Basic)(0.73)(0.51)(0.44)(1.83)(1.94)(3.64)(2.71)(5.09)
Earnings Per Share (Diluted)(0.73)(0.51)(0.44)(1.83)(1.94)(3.64)(2.71)(5.09)
Weighted Average Shares Outstanding (Basic)4,0483,9553,955976.001,096707.00620.00381.00
Weighted Average Shares Outstanding (Diluted)4,0483,9553,955976.001,096707.00620.00381.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About INM

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a stock listed on the Nasdaq Stock Market under the ticker symbol INM. It last traded at $14.70 (Nov 19, 2026, 7:00 PM ET), down 3.5% on the day. That gives InMed Pharmaceuticals a market capitalisation of $9.6M.

Over the past 52 weeks INM has traded between $5.75 and $23.30.

For the quarter ended Mar 31, 2026 it reported a net loss of $3.0M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$3.0M—
Dec 31, 2025$820.0K-$2.0M-247.3%
Sep 30, 2025$1.1M-$1.7M-154.2%
Jun 30, 2025$1.3M-$1.8M-137.1%

From InMed Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…